Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
DEL PRIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionUs Bancorp \de\
Latest Disclosed Ownership510,225 shares
Latest Disclosed Value $ 9,449,367
Us Bancorp \de\ reports 134.56% increase in ownership of TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 510,225 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $8,061,555 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 217,528 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 134.56% during the quarter. The current value of the position is $6,530,880 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 510,225 292,697 134.56 9,449 178.65 0.0035
2026-01-30 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 217,528 98,804 83.22 3,391 95.11 0.0040
2025-11-12 2025-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 118,724 6,250 5.56 1,738 0.00 0.0021
2025-07-24 2025-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 112,474 6,437 6.07 1,739 10.28 0.0022
2025-05-08 2025-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 106,037 -18,295 -14.71 1,577 -4.25 0.0021
2025-02-05 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 124,332 21,744 21.20 1,646 12.89 0.0022
2024-10-28 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 102,588 10,925 11.92 1,459 22.93 0.0019
2024-08-07 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 91,663 -24,464 -21.07 1,186 -26.47 0.0016
2024-05-08 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 116,127 23,450 25.30 1,613 22.01 0.0022
2024-02-09 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 92,677 -3,784 -3.92 1,323 -11.39 0.0020
2023-11-03 2023-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 96,461 -85,298 -46.93 1,492 -47.74 0.0024
2023-08-10 2023-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 181,759 -41,113 -18.45 2,855 -22.25 0.0046
2023-05-09 2023-03-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 222,872 19,782 9.74 3,673 15.91 0.0062
2023-02-13 2022-12-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 203,090 101,045 99.02 3,168 139.27 0.0056
2022-10-27 2022-09-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 102,045 1,302 1.29 1,324 -6.36 0.0027
2022-08-01 2022-06-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 100,743 -22,985 -18.58 1,414 -20.16 0.0027
2022-05-11 2022-03-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 123,728 16,298 15.17 1,771 20.89 0.0029
2022-02-11 2021-12-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 107,430 28,301 35.77 1,465 13.04 0.0023
2021-11-10 2021-09-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 79,129 24,849 45.78 1,296 41.79 0.0024
2021-08-05 2021-06-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 54,280 113 0.21 914 -7.58 0.0017
2021-04-28 2021-03-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 54,167 6,960 14.74 989 15.13 0.0020
2021-02-04 2020-12-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 47,207 1,896 4.18 859 6.31 0.0018
2020-11-10 2020-09-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 45,311 6,103 15.57 808 14.94 0.0020
2020-08-07 2020-06-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 39,208 7,096 22.10 703 44.35 0.0018
2020-05-13 2020-03-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 32,112 -13,771 -30.01 487 -46.19 0.0015
2020-02-04 2019-12-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 45,883 -5,438 -10.60 905 2.61 0.0023
2019-11-08 2019-09-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 51,321 8,006 18.48 882 15.14 0.0024
2019-08-13 2019-06-30 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 43,315 -13,483 -23.74 766 -33.79 0.0021
2019-05-08 2019-03-31 13F TAKEDA PHARMACEUTICAL COMMON STOCK 874060205 56,798 43,748 335.23 1,157 425.91 0.0033
2019-02-13 2018-12-31 13F TAKEDA PHARMACEUTICAL SP A D R COMMON STOCK 874060205 13,050 13,050 220 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.